Oncology Nursing News20h
Managing Toxicity in Later-Line HER2+ mBC Treatments: Real-World Insights and Mitigation Strategies for Optimal Patient QOLs
Experts discuss the patient case of Janet, a 58-year-old with her 2 positive metastatic breast cancer, and after 14 months on ...
Oncology Nursing News20h
Janet's Journey: Navigating HER2+ Metastatic Breast Cancer & Treatment Options
Patients with recurrent/metastatic HER2-positive breast cancer experienced durable response and manageable safety from ...